Global Core Electronic Medicinal Product Information (ePI), published by HL7 International / Biomedical Research and Regulation. This guide is not an authorized publication; it is the continuous build for version 1.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/HL7/emedicinal-product-info/ and changes regularly. See the Directory of published versions

• Narrative Content
• XML
• JSON
• TTL

: Composition - Diflucan SmPC

Raw xml | Download

<Composition xmlns="http://hl7.org/fhir">
  <id value="composition-diflucan"/>
  <meta>
    <versionId value="1"/>
    <lastUpdated value="2026-06-17T10:00:00Z"/>
    <profile
             value="http://hl7.org/fhir/uv/emedicinal-product-info/StructureDefinition/composition-epi-type1"/>
  </meta>
  <language value="en"/>
  <text>
    <status value="generated"/>
    <div xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en"><p>Diflucan Summary of Product Characteristics</p></div>
  </text>
  <identifier>
    <system value="http://example.org/identifier"/>
    <value value="composition-diflucan"/>
  </identifier>
  <version value="1.0"/>
  <status value="final"/>
  <type>
    <coding>
      <system value="https://spor.ema.europa.eu/rmswi"/>
      <code value="100000155532"/>
      <display value="Summary of Product Characteristics"/>
    </coding>
  </type>
  <subject>🔗 
    <reference
               value="http://hl7.org/fhir/uv/emedicinal-product-info/MedicinalProductDefinition/mpd-diflucan"/>
  </subject>
  <date value="2026-06-17"/>
  <author>🔗 
    <reference value="Organization/org-diflucan"/>
  </author>
  <title
         value="Diflucan 150 mg capsule - Summary of Product Characteristics"/>
  <section id="diflucan-root">
    <title value="SUMMARY OF PRODUCT CHARACTERISTICS"/>
    <code>
      <coding>
        <system value="https://spor.ema.europa.eu/rmswi"/>
        <code value="200000029791"/>
        <display value="SUMMARY OF PRODUCT CHARACTERISTICS"/>
      </coding>
    </code>
    <text>
      <status value="generated"/>
      <div xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en">Summary of Product Characteristics for Diflucan</div>
    </text>
    <section id="diflucan-4-1">
      <title value="4.1 Therapeutic indications"/>
      <code>
        <coding>
          <system value="https://spor.ema.europa.eu/rmswi"/>
          <code value="200000029799"/>
          <display value="4.1 Therapeutic indications"/>
        </coding>
      </code>
      <text>
        <status value="generated"/>
        <div xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en"><p>Treatment of mucosal and invasive candidiasis.</p></div>
      </text>
      <entry>🔗 
        <reference value="ClinicalUseDefinition/cud-diflucan-mucosal"/>
      </entry>
      <entry>🔗 
        <reference value="ClinicalUseDefinition/cud-diflucan-invasive"/>
      </entry>
    </section>
    <section id="diflucan-4-2">
      <title value="4.2 Posology and method of administration"/>
      <code>
        <coding>
          <system value="https://spor.ema.europa.eu/rmswi"/>
          <code value="200000029800"/>
          <display value="4.2 Posology and method of administration"/>
        </coding>
      </code>
      <text>
        <status value="generated"/>
        <div xml:lang="en" xmlns="http://www.w3.org/1999/xhtml" lang="en"><p>Dose depends on the indication and the patient population (see structured dosing). Renal impairment requires dose adjustment for multiple-dose therapy.</p></div>
      </text>
      <entry>🔗 
        <reference value="MedicationKnowledge/mk-diflucan"/>
      </entry>
      <entry>🔗 
        <reference value="ClinicalUseDefinition/cud-diflucan-renal"/>
      </entry>
    </section>
  </section>
</Composition>